News | May 07, 2026
Eli Lilly unveils $4.5 bn Indiana expansion
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
FY26 revenue rises 17% to Rs. 5,453 crore as US generics business jumps 49% and adjusted EBITDA margin improves to 26% for the quarter
The company also announced a major portfolio shift, planning to divest its Immunodiagnostics business in China, a unit that generated approximately 6% of its fiscal 2025 revenue
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
The private funding rose 38% amid growing international collaborations and CDMO demand
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
The initiative pairs consumer engagement with a public health message about prevention and early detection
Lifts full-year outlook as obesity drug boom accelerates
The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada
Subscribe To Our Newsletter & Stay Updated
